Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181550 | 0.82 | MGLL (0.38) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL29017 | 0.75 | MGLL (0.45) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL43978 | 0.75 | MGLL (0.45) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL16573659 | 0.72 | MGLL (0.38) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL13968985 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL13742892 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL969752 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL331187 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL22289873 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 | |
| SCHEMBL19546122 | 0.70 | MGLL (0.41) | MGLLGSK3AGSK3BGMNNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0665853-A1 | MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS | Diatide, Inc. (US) | 1995-08-09 | — | — | EP | claimed |
| WO-1994007918-A1 | MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS | DIATECH, INC. (US) | 1994-04-14 | — | — | WO | claimed |
| US-20160263003-A1 | Hair Color Smoothing Compositions and Methods | LIQWD, INC. | 2016-09-15 | — | — | US | disclosed |
| US-20160193129-A1 | Methods for Fixing Hair and Skin | LIQWD, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20150034119-A1 | Hair Color Smoothing Compositions and Methods | LIQWD, INC. (US) | 2015-02-05 | — | — | US | disclosed |
| US-20150037271-A1 | Methods for Fixing Hair and Skin | LIQWD, INC. (US) | 2015-02-05 | — | — | US | disclosed |
| US-20150037270-A1 | Compositions and Kits for Hair and Skin | LIQWD, INC. (US) | 2015-02-05 | — | — | US | disclosed |
| US-20120171601-A1 | FURAN DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR | RICOH COMPANY, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| EP-0665853-B1 | MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS | DIATIDE INC (US) | 2002-08-14 | — | — | EP | disclosed |
| US-6136782-A | LINEAR AND CYCLIC PEPTIDES THAT SPECIFICALLY BIND TO PLATELETS AND INHIBIT THEIR AGGREGATION | DIATIDE, INC. (US) | 2000-10-24 | — | — | US | disclosed |
| EP-0665853-A1 | MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS | Diatide, Inc. (US) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994007918-A1 | MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS | DIATECH, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160263003-A1 | Hair Color Smoothing Compositions and Methods | DNMT1, CAT, PTMA | MGLL 3218/4885GSK3A 3155/4885GSK3B 2867/4885 |
| US-20160193129-A1 | Methods for Fixing Hair and Skin | CUTA, SUCLG1, TST | MGLL 3461/4885GSK3A 4641/4885GSK3B 4631/4885 |
| US-20150037270-A1 | Compositions and Kits for Hair and Skin | CUTA, TST, GCLC | MGLL 3563/4885GSK3A 4532/4885GSK3B 4546/4885 |
| US-20150037271-A1 | Methods for Fixing Hair and Skin | CUTA, SUCLG1, TST | MGLL 3461/4885GSK3A 4641/4885GSK3B 4631/4885 |
| US-20150034119-A1 | Hair Color Smoothing Compositions and Methods | DNMT1, UNG, CAT | MGLL 3247/4885GSK3A 3314/4885GSK3B 3066/4885 |
| US-20120171601-A1 | FURAN DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR | CYP1A1, AR, CYP1B1 | MGLL 4606/4885GSK3A 4728/4885GSK3B 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.